Brette Trost

Latham & Watkins represented TKO Group Holdings, Inc. in the offering; Kirkland & Ellis represented the selling stockholder, while Davis Polk & Wardwell advised the representative...

Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...

Davis Polk & Wardwell is advising Ferrara Candy Company on the transaction, and Foley & Lardner is advising Jelly Belly Candy Company. Ferrara Candy Company announced...

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Natera, and Davis Polk & Wardwell advised the representatives of the several underwriters on the offering. Natera, Inc....

Davis Polk & Wardwell advised Upgrade, Inc. on the transaction. Upgrade, Inc. announced the acquisition of Uplift, Inc., the leading provider of Buy Now Pay Later (BNPL)...

Davis Polk & Wardwell is advising Centogene N.V., while Latham & Watkins is advising Lifera in the transaction. Centogene N.V., a life science company focused on...

Weil advised Estée Lauder on the offering, and Davis Polk advised the joint book-running managers. Estée Lauder Companies Inc. announced an SEC-registered debt offering of $700 million...

Davis Polk is advising TPG on the deal. TPG (NASDAQ: TPG) and Thomson Reuters (TSX/NYSE: TRI) announced that they have signed a definitive agreement for TPG...

NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...

Davis Polk and Hogan Lovells advised Precigen on the offering, and Goodwin Procter advised the underwriters involved. Precigen Inc. announced the SEC-registered offering of an aggregate of...

UBS Investment Bank acted as exclusive financial advisor and McDermott Will & Emery LLP served as legal counsel to Wells. Morgan Stanley & Co. International plc...

Sidley Austin advised Biodesix, while Davis Polk & Wardwell advised the underwriter William Blair in the offering. Biodesix, Inc. executed the offering of 35,075,000 shares (including the...